H. Pahl

H. Pahl, J. Wehrle, N. von Bubnoff, 2014, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun *

H. Pahl, A. Covacci, M. Kist, 2000, The Journal of Biological Chemistry.

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.

H. Heimpel, M. Griesshammer, H. Pahl, 2005, Blood.

Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera.

C. Busse, H. Pahl, S. Klippel, 2002, Blood.

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

C. Mueller-Dieckmann, P. Auberger, A. Livolsi, 1996, Cell.

The Hen or the Egg: Inflammatory Aspects of Murine MPN Models

H. Pahl, J. Jutzi, 2015, Mediators of inflammation.

Haematopoietic stem cell survival and transplantation efficacy is limited by the BH3-only proteins Bim and Bmf

S. Geley, C. Niemeyer, H. Pahl, 2012, EMBO molecular medicine.

Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders.

H. Pahl, S. Klippel, 2004, Pathologie-biologie.

Molecular Markers in Myeloproliferative Disorders: From Classification to Prognosis?

H. Pahl, 2003, Hematology.

Towards a molecular understanding of polycythemia rubra vera.

H. Pahl, 2000, European journal of biochemistry.

Inhibition of Activator Protein 1 by Barbiturates Is Mediated by Differential Effects on Mitogen-Activated Protein Kinases and the Small G Proteins Ras and Rac-1

T. Loop, H. Pahl, M. Humar, 2004, Journal of Pharmacology and Experimental Therapeutics.

Helenalin, an Anti-Inflammatory Sesquiterpene Lactone from Arnica, Selectively Inhibits Transcription Factor NF-κB

H. Pahl, I. Merfort, T. Schmidt, 1997 .

The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice.

R. Perlmutter, D. Tenen, D. Morris, 1995, Blood.

Endoplasmicreticulum-induced signal transduction and gene expression.

H. Pahl, P. Baeuerle, Heiki L. Pahl, 1997, Trends in cell biology.

Reactive oxygen intermediates as second messengers of a general pathogen response.

H. Pahl, P. Baeuerle, R. Rupec, 1996, Pathologie-biologie.

Krüppel-like factor 15 regulates BMPER in endothelial cells.

C. Bode, C. Patterson, H. Pahl, 2010, Cardiovascular research.

Many roads lead to MPN.

H. Pahl, 2014, Blood.

Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation.

H. Pahl, S. Bereswill, A. Covacci, 1998, Infection and immunity.

Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells.

T. Loop, H. Pahl, M. Humar, 2004, Molecular pharmacology.

Study of sesquiterpene lactones from Milleria quinqueflora on their anti-inflammatory activity using the transcription factor NF-kappa B as molecular target.

H. Pahl, I. Merfort, R. Murillo, 2000, Phytochemistry.

Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression

R. Oostendorp, H. Pahl, J. Duyster, 2016, The Journal of experimental medicine.

Thiopental Inhibits the Activation of Nuclear Factor &kgr;B

T. Loop, H. Pahl, M. Humar, 2002 .

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.

M. Lübbert, G. Meinhardt, H. Pahl, 2000, Blood.

A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B.

H. Pahl, P. Baeuerle, S. Bereswill, 1997, Journal of immunology.

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.

M. Griesshammer, T. Barbui, A. Dueck, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thiopental Inhibits Tumor Necrosis Factor &agr;–induced Activation of Nuclear Factor &kgr;B through Suppression of I&kgr;B Kinase Activity

T. Loop, H. Pahl, M. Humar, 2003 .

Thiopental Inhibits Tumor Necrosis Factor (cid:1) –induced Activation of Nuclear Factor (cid:2) B through Suppression of I (cid:2) B Kinase Activity

T. Loop, H. Pahl, M. Humar, 2003 .

Reduced activation of immunomodulatory transcription factors during positive end-expiratory pressure adjustment based on volume-dependent compliance in isolated perfused rabbit lungs.

J. Guttmann, H. Pahl, J. Muehlschlegel, 2005, British journal of anaesthesia.

Dobutamine Inhibits Phorbol-Myristate-Acetate-Induced Activation of Nuclear Factor-&kgr;B in Human T Lymphocytes In Vitro

T. Loop, H. Pahl, M. Humar, 2004, Anesthesia and analgesia.

Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.

H. Pahl, P. Stieber, C. Schambeck, 1995, Urology.

Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.

M. Griesshammer, H. Pahl, H. Gisslinger, 2005, Haematologica.

A novel role for NF-E 2 in erythroid maturation by modulation of mitochondrial autophagy

H. Pahl, J. Wehrle, K. Aumann, 2016 .

Volatile Anesthetics Induce Caspase-dependent, Mitochondria-mediated Apoptosis in Human T Lymphocytes In Vitro

C. Borner, T. Loop, H. Pahl, 2005, Anesthesiology.

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

A. Dueck, R. Hoffman, H. Pahl, 2019, Leukemia & lymphoma.

A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.

O. Linder, H. Pahl, Y. Brandberg, 2006, Cancer.

PRV-1 mRNA expression discriminates two types of essential thrombocythemia

H. Heimpel, M. Griesshammer, H. Pahl, 2004, Annals of Hematology.

A JAK-in-the-cell cycle.

H. Pahl, 2012, Blood.

Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera

K. Schwarz, C. Niemeyer, H. Cario, 2008, British journal of haematology.

Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia.

H. Pahl, M. Björkholm, G. Birgegard, 2006, Haematologica.

Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies.

T. Haferlach, S. Schnittger, R. Kuiper, 2012, Blood.

A phase II trial of pegylated interferon α‐2b therapy for polycythemia vera and essential thrombocythemia

O. Linder, H. Pahl, Y. Brandberg, 2006 .

A Phase II Trial of Pegylated Interferon -2b Therapy for Polycythemia Vera and Essential Thrombocythemia Feasibility, Clinical and Biologic Effects, and Impact on Quality of Life

O. Linder, H. Pahl, Y. Brandberg, 2006 .

Assaying NF-kappa B and AP-1 DNA-binding and transcriptional activity.

H. Pahl, J. M. Mueller, 2000, Methods in molecular biology.

Proteins Encoded by the cagPathogenicity Island of Helicobacter pylori Are Required for NF-κB Activation

H. Pahl, S. Bereswill, A. Covacci, 1998, Infection and Immunity.

Comparison of methods for polycythemia rubra vera-1 mRNA quantification in whole-blood leukocytes and purified granulocytes.

H. Pahl, P. Johansson, L. Palmqvist, 2004, Clinical chemistry.

Elevated Nuclear Factor Erythroid‐2 Levels Promote Epo‐Independent Erythroid Maturation and Recapitulate the Hematopoietic Stem Cell and Common Myeloid Progenitor Expansion Observed in Polycythemia Vera Patients

H. Pahl, Ruzhica Bogeska, 2013, Stem cells translational medicine.

Sevoflurane Inhibits Phorbol-Myristate-Acetate-induced Activator Protein-1 Activation in Human T Lymphocytes in Vitro: Potential Role of the p38-Stress Kinase Pathway

T. Loop, F. Musshoff, B. Madea, 2004, Anesthesiology.

Sevoflurane-Mediated Activation of p38-Mitogen-Activated Stresskinase is Independent of Apoptosis in Jurkat T-Cells

T. Loop, H. Pahl, M. Humar, 2008, Anesthesia and analgesia.

Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.

H. Döhner, S. Stilgenbauer, H. Pahl, 1999, Blood.

Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions.

H. Pahl, I. Merfort, T. Schmidt, 1999, Bioorganic & medicinal chemistry.

Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia

H. Pahl, T. Brummer, H. Becker, 2019, HemaSphere.

Repression of T-cell function by thionamides is mediated by inhibition of the AP-1/NFAT pathway and is associated with a common structure

T. Loop, H. Pahl, M. Humar, 2007 .

p38β-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro.

T. Loop, H. Pahl, M. Humar, 2011, European journal of pharmacology.

Differential Effects of Volatile Anesthetics on Hepatic Heme Oxygenase–1 Expression in the Rat

T. Loop, H. Pahl, M. Humar, 2002, Anesthesiology.

Clinical and hematological presentation of children and adolescents with polycythemia vera

H. Cario, H. Pahl, M. McMullin, 2009, Annals of Hematology.

Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models

H. Pahl, T. Basu, Nikolaos Karantzelis, 2021, HemaSphere.

DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs.

W. Colledge, H. Pahl, H. Schaefer, 2002, Biological chemistry.

Regulation of the transcription factors NF-kappa B and AP-1 by redox changes.

H. Pahl, P. Baeuerle, M. Meyer, 1994, Chemico-biological interactions.

Studies on the Anti-Inflammatory Activity of Phytopharmaceuticals Prepared from Arnica Flowers1

S. Laufer, H. Pahl, I. Merfort, 2002, Planta medica.

Inhibition of the transcription factor NF-kappa B by sesquiterpene lactones from Podachaenium eminens.

H. Pahl, I. Merfort, R. Murillo, 2000, Planta medica.

Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.

M. Lübbert, G. Meinhardt, H. Pahl, 2000, Blood.

NFE2 regulates transcription of multiple enzymes in the heme biosynthesis pathway

H. Pahl, J. Wehrle, L. Rheinemann, 2014, Haematologica.

Essential versus reactive thrombocythemia in children: Retrospective analyses of 12 cases

C. Niemeyer, H. Pahl, C. Kratz, 2007, Pediatric blood & cancer.

Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis.

K. Schwarz, S. Rives, H. Cario, 2007, Haematologica.

Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.

H. Pahl, P. Johansson, J. Spivak, 2005, Haematologica.

Carbon Monoxide Inhalation Reduces Pulmonary Inflammatory Response during Cardiopulmonary Bypass in Pigs

Ulrich Goebel, Matthias Siepe, Christian Schlensak, 2008, Anesthesiology.

Protective effects of inhaled carbon monoxide in pig lungs during cardiopulmonary bypass are mediated via an induction of the heat shock response.

T. Loop, H. Pahl, C. Schwer, 2009, British journal of anaesthesia.

Tissue microarray technique is applicable to bone marrow biopsies of myeloproliferative neoplasms

M. Werner, H. Pahl, D. Hauschke, 2016, Histochemistry and Cell Biology.

Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment

K. Metzeler, R. Claus, M. Lübbert, 2018, British journal of haematology.

Study of three sesquiterpene lactones from Tithonia diversifolia on their anti-inflammatory activity using the transcription factor NF-kappa B and enzymes of the arachidonic acid pathway as targets.

H. Pahl, I. Merfort, G. Mora, 1998, Planta medica.

Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action.

H. Pahl, I. Merfort, T. Schmidt, 1999, Bioorganic & medicinal chemistry.

Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B

H. Pahl, P. Baeuerle, P A Baeuerle, 1995, Journal of virology.

The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65*

H. Pahl, I. Merfort, A. Knorre, 1998, The Journal of Biological Chemistry.

Signal transduction from the endoplasmic reticulum to the cell nucleus.

H. Pahl, 1999, Physiological reviews.

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB

K. Schulze-Osthoff, H. Pahl, T. Decker, 1996, The Journal of experimental medicine.

Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones*

H. Pahl, I. Merfort, G. Mora, 2001, The Journal of Biological Chemistry.

Myeloproliferative (MPN) Symptom Burden Response Thresholds: Assessment Of MPN-SAF TSS Quartiles As Potential Markers Of Symptom Response

M. Griesshammer, T. Barbui, A. Dueck, 2013 .

Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo

D. Schadendorf, I. Fichtner, H. Pahl, 1996, The Journal of cell biology.

Palpitations And Arrhythmia In 3649 High-Risk Patients With Essential Thrombocythemia : Results From The Prospective Long-Term Observational Exels Study

T. Barbui, A. Dueck, R. Mesa, 2016 .

Chromosomal abnormalities and molecular markers in myeloproliferative disorders.

A. Bench, H. Pahl, 2005, Seminars in hematology.

MyD88, an Adapter Protein Involved in Interleukin-1 Signaling*

F. Martinon, K. Burns, J. Tschopp, 1998, The Journal of Biological Chemistry.

The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.

H. Pahl, J. Wehrle, S. Schwemmers, 2020, Experimental hematology.

The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.

L. Bullinger, K. Döhner, V. Gaidzik, 2017, Experimental hematology.

[15]Identification of transcription factors and their target genes

H. Pahl, P. Baeuerle, 1996 .

Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention

H. Pahl, P. Baeuerle, M. Sester, 1996, The Journal of cell biology.

A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF‐kappa B.

H. Pahl, P. Baeuerle, 1995, The EMBO journal.

Thiopental Protects Human T Lymphocytes from Apoptosis in Vitro via the Expression of Heat Shock Protein 70

T. Loop, H. Pahl, M. Humar, 2008, Journal of Pharmacology and Experimental Therapeutics.

Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

C. Mueller-Dieckmann, P. Auberger, A. Livolsi, 1996, Cell.

The mitogen-activated protein kinase p38 regulates activator protein 1 by direct phosphorylation of c-Jun.

T. Loop, H. Pahl, M. Humar, 2007, The international journal of biochemistry & cell biology.

Regulation of the transcription factors NF-kappa B and AP-1 by redox changes.

H. Pahl, P. Baeuerle, M. Meyer, 1994, Chemico-biological interactions.

Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy.

M. Werner, H. Pahl, J. Duyster, 2020, Leukemia research.

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.

Christopher J. Ott, H. Pahl, J. Wehrle, 2018, Blood.

Activators and target genes of Rel/NF-kappaB transcription factors.

H. Pahl, H L Pahl, 1999, Oncogene.

Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors

S. Braun, J. Penninger, M. Werner, 2013, Leukemia.

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

D. Steinemann, L. Bullinger, H. Pahl, 2019, Blood.

JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.

H. Pahl, P. Johansson, C. Waller, 2007, Experimental hematology.

Characterization of the myeloid-specific CD11b promoter.

D. Tenen, H. Pahl, A. Rosmarin, 1992, Blood.

The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies

H. Pahl, J. Jutzi, H. F. Staehle, 2021, Biomolecules.

Jmjd1c is dispensable for healthy adult hematopoiesis and Jak2V617F-driven myeloproliferative disease initiation in mice

H. Pahl, A. Gruender, J. Jutzi, 2020, PloS one.

Repression of T-Cell Function by Thionamides Is Mediated by Inhibition of the Activator Protein-1/Nuclear Factor of Activated T-Cells Pathway and Is Associated with a Common Structure

T. Loop, H. Pahl, M. Humar, 2007, Molecular Pharmacology.

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

T. Barbui, G. Barosi, A. Vannucchi, 2016, Leukemia.

Diagnostic approaches to polycythemia vera in 2004

H. Pahl, 2004, Expert review of molecular diagnostics.

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

K. Döhner, M. Griesshammer, T. Barbui, 2016, Haematologica.

Familial polycythemia vera with Budd–Chiari syndrome in childhood

K. Schwarz, H. Cario, H. Pahl, 2003, British journal of haematology.

Thionamides Inhibit the Transcription Factor Nuclear Factor-κB by Suppression of Rac1 and Inhibitor of κB Kinase α

T. Loop, H. Pahl, M. Humar, 2008, Journal of Pharmacology and Experimental Therapeutics.

Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha.

T. Loop, H. Pahl, M. Humar, 2008, The Journal of pharmacology and experimental therapeutics.

Characterization of PRV-1, a Novel Hematopoietic Cell Surface Marker Overexpressed in Polycythemia Rubra Vera

H. Pahl, 2004 .

The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity.

D. Tenen, H. Pahl, R. Scheibe, 1993, The Journal of biological chemistry.

Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis.

J. Simon, A. Aruffo, H. Pahl, 1999, Cancer research.

LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone

J. Teruya-Feldstein, R. Levine, H. Rienhoff, 2018, HemaSphere.

Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside

T. Loop, H. Pahl, 2003 .

A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2

D. Steinemann, M. Werner, R. Schüle, 2012, The Journal of experimental medicine.

MPN patients harbor recurrent truncating mutations in transcription factor NF-E2

K. Döhner, H. Pahl, J. Jansen, 2013, The Journal of experimental medicine.

Isoflurane pretreatment lowers portal venous resistance by increasing hepatic heme oxygenase activity in the rat liver in vivo.

T. Loop, H. Pahl, M. Humar, 2004, Journal of hepatology.

PRV-1 mRNA expression and other molecular markers in polycythemia rubra vera.

H. Pahl, 2003, Current hematology reports.

Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

F. Colland, S. Fulda, I. Fichtner, 2015, Oncogenesis.

Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice

H. Pahl, J. Nofer, C. Müller-Tidow, 2019, Leukemia.

Phase I dose escalation study of lestaurtinib in patients with myelofibrosis

V. Najfeld, R. Hoffman, H. Pahl, 2015, Leukemia & lymphoma.

Control of gene expression by proteolysis.

H. Pahl, P. Baeuerle, P A Baeuerle, 1996, Current opinion in cell biology.

Comprehensive Mu-opioid-receptor Genotyping

H. Pahl, P. Johansson, L. Palmqvist, 2004 .

Tyrosine Phosphorylation of IkB-a Activates NF-kB without Proteolytic Degradation of IkB-a

C. Mueller-Dieckmann, P. Auberger, A. Livolsi, 1996 .

ΔF508-CFTR Causes Constitutive NF-κB Activation through an ER-Overload Response in Cystic Fibrosis Lungs

W. Colledge, H. Pahl, H. Schaefer, 2002 .

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells

H. Pahl, J. Peeken, A. Gruender, 2023, Leukemia.

Structural analysis of the CD11b gene and phylogenetic analysis of the alpha-integrin gene family demonstrate remarkable conservation of genomic organization and suggest early diversification during evolution.

D. Tenen, H. Pahl, J. Fleming, 1993, Journal of immunology.

Conventional therapeutic options have limited impact on MPN symptoms: Insights from a prospective analysis of the MPN-SAF TSS

T. Barbui, A. Dueck, R. Mesa, 2012 .

Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation

C. Borner, H. Pahl, P. Brauns-Schubert, 2014, Oncogene.

Anti-inflammatory activities of hypocretenolides from Leontodon hispidus.

H. Stuppner, H. Pahl, I. Merfort, 1999, Planta medica.

Activation of cellular death programs associated with immunosenescence-like phenotype in TPPII knockout mice

P. van Endert, H. Pahl, M. Freudenberg, 2008, Proceedings of the National Academy of Sciences.

A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biological effects, and impact on quality of life

Ø. Bruserud, O. Linder, H. Pahl, 2006 .

New C3H KitN824K/WT cancer mouse model develops late-onset malignant mammary tumors with high penetrance

H. Fuchs, M. D. de Angelis, V. Gailus-Durner, 2022, bioRxiv.

Systematic Evaluation of DNA-Based Quantitative-Polymerase Chain Reaction (Q-PCR) Assays to Track Treatment Response in Patients with JAK2-V617F Associated Myeloproliferative Neoplasms: A Joint European LeukemiaNet/ MPN&MPNr-EuroNet Study

T. Barbui, P. Guglielmelli, A. Pancrazzi, 2011 .

Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.

H. Pahl, P. Stieber, D. Nagel, 1997, Anticancer research.

Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.

H. Pahl, P. Stieber, U. Hasholzner, 1996, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

The AML1/ETO target gene LAT2 interferes with differentiation of normal hematopoietic precursor cells.

Michael Lübbert, M. Lübbert, H. Pahl, 2014, Leukemia research.

Symptom Burden As Primary Driver for Therapy in Patients with Myelofibrosis: An Analysis By MPN International Quality of Life Study Group

M. Griesshammer, T. Barbui, A. Dueck, 2016 .

Thiopental inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappaB through suppression of kappaB kinase activity.

T. Loop, H. Pahl, M. Humar, 2003, Anesthesiology.

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

K. Döhner, M. Griesshammer, T. Barbui, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF‐E2

T. Maiwald, J. Timmer, C. Kreutz, 2005, British journal of haematology.

Transcription factor nuclear factor erythroid-2 mediates expression of the cytokine interleukin 8, a known predictor of inferior outcome in patients with myeloproliferative neoplasms

H. Pahl, J. Wehrle, A. Bulashevska, 2013, Haematologica.